Slaven Erceg

Efficient differentiation of human embryonic stem cells into functional cerebellar-like cells.

Transplanted oligodendrocytes and motoneuron progenitors generated from human embryonic stem cells promote locomotor recovery after spinal cord transection.

Non-coding RNAs in pluripotency and neural differentiation of human pluripotent stem cells.

Complete rat spinal cord transection as a faithful model of spinal cord injury for translational cell transplantation.

Human iPSC derived disease model of MERTK-associated retinitis pigmentosa.

Connexin 50 Expression in Ependymal Stem Progenitor Cells after Spinal Cord Injury Activation.

Stem Cells and Labeling for Spinal Cord Injury.

Highly Efficient Neural Conversion of Human Pluripotent Stem Cells in Adherent and Animal-Free Conditions.

hiPSC Disease Modeling of Rare Hereditary Cerebellar Ataxias: Opportunities and Future Challenges.

Generation of a human iPSC line from a patient with retinitis pigmentosa caused by mutation in PRPF8 gene.

Stem Cell-Based Therapy in Transplantation and Immune-Mediated Diseases.

FM19G11 and Ependymal Progenitor/Stem Cell Combinatory Treatment Enhances Neuronal Preservation and Oligodendrogenesis after Severe Spinal Cord Injury.

Concise Review: Human Induced Pluripotent Stem Cell Models of Retinitis Pigmentosa.

Generation of a human iPSC line from a patient with congenital glaucoma caused by mutation in CYP1B1 gene.

Generation of a human iPSC line by mRNA reprogramming.

Corrigendum to Generation of a human iPSC line by mRNA reprogramming. Stem Cell Res., Volume 28, April 2018, Pages 157-160.

Generation of a human iPSC line from a patient with autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS) caused by mutation in SACSIN gene.

Neural Stem Cells Derived from Human-Induced Pluripotent Stem Cells and Their Use in Models of CNS Injury.

Generation of a human iPSC line from a patient with Leber congenital amaurosis caused by mutation in AIPL1.

Generation of human induced pluripotent stem cell (iPSC) line from an unaffected female carrier of mutation in SACSIN gene.

Generation of gene-corrected human induced pluripotent stem cell lines derived from retinitis pigmentosa patient with Ser331Cysfs*5 mutation in MERTK.

The identification of small molecules that stimulate retinal pigment epithelial cells: potential novel therapeutic options for treating retinopathies.

Assessment of Toxic Effects of Ochratoxin A in Human Embryonic Stem Cells.

Generation of an iPSC line from a retinitis pigmentosa patient carrying a homozygous mutation in CERKL and a healthy sibling.

Deciphering retinal diseases through the generation of three dimensional stem cell-derived organoids: Concise Review.

Transcriptome-based molecular staging of human stem cell-derived retinal organoids uncovers accelerated photoreceptor differentiation by 9-cis retinal.

Organized Neurogenic-Niche-Like Pinwheel Structures Discovered in Spinal Cord Tissue-Derived Neurospheres.

Retinal Organoids derived from hiPSCs of an AIPL1-LCA Patient Maintain Cytoarchitecture despite Reduced levels of Mutant AIPL1.

Glaucoma as a Neurodegenerative Disease Caused by Intrinsic Vulnerability Factors.

Activation of Neurogenesis in Multipotent Stem Cells Cultured In Vitro and in the Spinal Cord Tissue After Severe Injury by Inhibition of Glycogen Synthase Kinase-3.

Unraveling the Developmental Roadmap toward Human Brown Adipose Tissue.

Gene Correction Recovers Phagocytosis in Retinal Pigment Epithelium Derived from Retinitis Pigmentosa-Human-Induced Pluripotent Stem Cells.

Mutant PRPF8 Causes Widespread Splicing Changes in Spliceosome Components in Retinitis Pigmentosa Patient iPSC-Derived RPE Cells.

Subretinal Implantation of Human Primary RPE Cells Cultured on Nanofibrous Membranes in Minipigs.